MKI67 and mesenchymal cell neoplasm: Weak CD34 signaling suggests a different direction compared to mesenchymal tumors with malignant potential.[10] Additionally, Ki67 expression is weak in these benign tumors, with most cases showing < 5% expression, indicating a low mitotic rate and a tendency toward benign tumor behavior.